Who
Antonio R. Pera
Director
Company insider
Files Form 4 as: Director, ANI Pharmaceuticals; President, Par Pharmaceutical, Endo International.
In numbers
- Trades disclosed
- 29
- Buys
- 1
- Sells
- 4
- Bought
- $127K
- Sold
- $1.8M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 21 Feb 2017
- Last trade
- 21 May 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 3 Sep 2025filed 4 Sep 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $692K7,292 at $94.94 | filing |
| 20 Aug 2025filed 20 Aug 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $486K5,421 at $89.73 | filing |
| 22 May 2025filed 27 May 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,336 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,410 at $0.00 | filing |
| 4 Mar 2024filed 6 Mar 2024 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $456K7,000 at $65.20 | filing |
| 14 Aug 2023filed 15 Aug 2023 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $181K3,000 at $60.37 | filing |
| 23 May 2023filed 24 May 2023 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,865 at $0.00 | filing |
| 27 Apr 2022filed 29 Apr 2022 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —10,049 at $0.00 | filing |
| 7 Dec 2021filed 9 Dec 2021 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $127K3,000 at $42.26 | filing |
| 23 Mar 2021filed 25 Mar 2021 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —9,292 at $0.00 | filing |
| 5 Aug 2020filed 7 Aug 2020 | ANIP ANI Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —16,024 at $0.00 | filing |
| 5 Aug 2020filed 7 Aug 2020 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —7,421 at $0.00 | filing |
| 2 Apr 2019filed 4 Apr 2019 | Endo International | SEC FORM 4 Code F | $95K11,669 at $8.10 | filing |
| 29 Mar 2019filed 2 Apr 2019 | Endo International | SEC FORM 4 Code A | —46,973 | filing |
| 23 Feb 2019filed 26 Feb 2019 | Endo International | SEC FORM 4 Code F | $1,955186 at $10.51 | filing |
| 21 Feb 2019filed 25 Feb 2019 | Endo International | SEC FORM 4 Code F | $26K2,528 at $10.38 | filing |
| 1 Oct 2018filed 2 Oct 2018 | Endo International | SEC FORM 4 Code F | $2,114124 at $17.05 | filing |
| 10 Aug 2018filed 14 Aug 2018 | Endo International | SEC FORM 4 Code F | $88K5,585 at $15.82 | filing |
News
No headline names them, or the companies they trade most, lately.